Zydus Lifesciences Limited is involved in the research, development, production, marketing, distribution, and sale of pharmaceutical products.
## Business Segments
The company operates through various business segments that cover a broad range of pharmaceutical products and services. The primary segments include Formulations, Active Pharmaceutical Ingredients (APIs), and Consumer Healthcare Products.
The Formulations segment is central to the company's operations, focusing on the development...
Zydus Lifesciences Limited is involved in the research, development, production, marketing, distribution, and sale of pharmaceutical products.
## Business Segments
The company operates through various business segments that cover a broad range of pharmaceutical products and services. The primary segments include Formulations, Active Pharmaceutical Ingredients (APIs), and Consumer Healthcare Products.
The
Formulations
segment is central to the company's operations, focusing on the development and production of a diverse range of pharmaceutical products. This segment includes prescription drugs, over-the-counter (OTC) products, and specialty medications designed to address various health conditions and enhance patient outcomes.
The
Active Pharmaceutical Ingredients
segment plays a crucial role in the company's overall business strategy. The company manufactures a variety of APIs that serve as the foundational components for its formulations.
The
Consumer Healthcare
segment is another essential aspect of the company's business model. This segment concentrates on offering health and wellness products that meet consumers' everyday needs. The company's consumer healthcare products comprise dietary supplements, personal care items, and wellness solutions aimed at promoting overall health and well-being.
## Business Strategy
The company's business strategy revolves around innovation, quality, and sustainability. By emphasizing innovation, the company aims to distinguish itself in the competitive pharmaceutical industry and establish a robust market presence.
The company's dedication to quality is evident in its rigorous manufacturing processes and adherence to regulatory standards. It ensures that all its products meet the highest quality criteria, crucial for upholding customer trust and satisfaction. This quality focus extends across all business aspects, from raw material sourcing to final product delivery.
Sustainability is another pivotal element of the company's business strategy. The company acknowledges the significance of environmental responsibility and is dedicated to reducing its ecological impact. Customer engagement and feedback are also prioritized as part of its business strategy.
## Products and Services
The company provides a comprehensive array of products and services catering to diverse healthcare needs. Its product portfolio includes prescription drugs, over-the-counter (OTC) products, active pharmaceutical ingredients (APIs), and consumer healthcare items.
The prescription medications cover various therapeutic areas such as cardiology, oncology, diabetes, and infectious diseases. The company is committed to developing innovative therapies addressing complex health conditions and enhancing patient outcomes.
In addition to prescription medications, the company offers OTC products providing accessible healthcare solutions for consumers. These products aim to tackle common health issues and promote overall well-being. The consumer healthcare segment encompasses dietary supplements, personal care items, and wellness solutions tailored to meet consumers' diverse needs. The company also manufactures APIs, serving as the foundational elements for its formulations.
## Geographical Markets Served
The company operates in diverse geographical markets, extending its presence to both domestic and international customers. Its global footprint is supported by a network of subsidiaries and partnerships facilitating product distribution across different regions.
## Acquisitions
In recent years, the company has pursued strategic acquisitions to bolster its market position. Notably, it established Zydus Pharmaceuticals UK Limited in the United Kingdom as a wholly owned subsidiary on February 8, 2023. Additionally, Zynext Ventures Pte. Ltd. was set up in Singapore on February 21, 2023, followed by the incorporation of Zynext Ventures USA LLC in the United States on March 3, 2023.
## Customers
The company serves a diverse customer base comprising healthcare providers, pharmacies, hospitals, and consumers.
## History
Formerly known as Cadila Healthcare Limited, the company changed its name to Zydus Lifesciences Limited in February 2022. It was founded in 1952 and incorporated in 1995.
Das Analystenkursziel zeigt auf einen Blick die Mindest-, Höchst- und Durchschnittserwartung der Analysten.
